Theratechnologies Propriété du management
Quel est le Propriété du management de Theratechnologies?
Le Propriété du management de Theratechnologies, Inc. est 1.22%
Quelle est la définition de Propriété du management?
La propriété d'un initié est calculée en divisant le nombre total d'actions possédées par des initiés (actionnaires détenant plus de 5% de la société ou un dirigeant ou un administrateur de la société) par le nombre total d'actions en circulation.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Propriété du management des entreprises dans Health Care secteur sur TSX par rapport à Theratechnologies
Que fait Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Entreprises avec propriété du management similaire à Theratechnologies
- Community System a Propriété du management de 1.22%
- Principal a Propriété du management de 1.22%
- Principal Inc a Propriété du management de 1.22%
- Houghton Mifflin Harcourt Co a Propriété du management de 1.22%
- Real Estate Credit Investments a Propriété du management de 1.22%
- Eagle Point Credit Inc a Propriété du management de 1.22%
- Theratechnologies a Propriété du management de 1.22%
- Theratechnologies a Propriété du management de 1.22%
- RPM International a Propriété du management de 1.23%
- Takeda Pharmaceutical Co a Propriété du management de 1.23%
- Myers Industries a Propriété du management de 1.23%
- Devro Plc a Propriété du management de 1.24%
- J Sainsbury Plc a Propriété du management de 1.24%